Effect of hand segment chemistry and strain on the stability of polyurethanes: in vivo biostability.

We investigated four polyurethanes that were synthesized with different hard segments and four commercial polyurethanes for in vivo biostability. The four polyurethanes with the varying hard segments were based on a 3:2:1 mole ratio of methylene diphenylene diisocyanate (MDI) or methylene dicyclohexane diisocyanate (H12MDI), butanediol (BD) or ethylene diamine (ED) and polytetramethylene oxide (PTMO) (MW = 1000). Four commercial polyurethanes were also used: Biomer, Pellethane, Medtronic experimental C-19 (C-19) and Medtronic experimental C-36 (C-36). Films of the polymers were implanted subcutaneously in rats for up to 12 wk to assess their biostability. Polymer films were implanted either with a 100% strain applied or in the unstrained state. Measurement of tensile properties, molecular weight and surface properties before and after implantation assessed the stability of each of the polymers. Surface cracking was observed with scanning electron microscopy and the extent and depth of cracking were determined. Pellethane, C-19 and C-36 showed the least evidence of degradation, although all underwent strain-induced phenomena that decreased their tensile elongation when an external force was applied. After implantation, the BD chain-extended polymers retained their tensile properties better than ED chain-extended polymers. H12MDI-based polyurethanes were more susceptible to surface cracking and molecular weight changes than MDI-based polyurethanes, possibly due to the lack of a crystallizable hard segment.

Thrombus deposition on polyurethanes designed for biomedical applications.

Thrombogenicity was assessed by measuring the amount of 111In-platelets and 125I-fibrinogen deposited on the inner luminal surface of six polyurethanes for up to 60 min of blood contact in a canine ex-vivo shunt model. Commercial and laboratory synthesized polymers were examined. Two of the commercially synthesized polyurethanes (Biostable PURs) do not contain ether linkages in the polymer backbone and have previously shown resistance to oxidative and hydrolytic degradation. Static contact angle measurements, dynamic contact angle measurements, and ESCA were used to characterize the surfaces of these polyurethanes. The effectiveness of an acetone extraction used to remove extrusion waxes from Pellethane 2363-80A was similarly studied. Both Pellethane 2363-80A and the ether-free materials had relatively nonthrombogenic surfaces, as indicated by low platelet and fibrinogen deposition, making them potentially good candidates for biomedical applications.

Biostability and blood-contacting properties of sulfonate grafted polyurethane and Biomer.

Sulfonate-containing polyurethanes were evaluated for in vivo biodegradation using subcutaneously implanted tensile bars. In addition, these anionically charged polyurethanes were evaluated for in vivo activation of human complement C3a and ex vivo platelet deposition in arteriovenously-shunted canines. The sulfonate derivatized polymers included laboratory synthesized polyurethane and Biomer. Other polymers used for references included Intramedic polyethylene, Silastic and a poly(ethylene oxide) based polyurethane. The biodegradation results indicated that Biomer and the laboratory sulfonated Biomer (both manufactured with stabilizers), remained mechanically stable, retaining both tensile strength and elasticity after 4 weeks of subcutaneous implantation. The unstabilized polyurethanes (with or without sulfonation), however, showed marked cracking and a loss of mechanical properties after the same period of subcutaneous implantation. Sulfonated polyurethanes depressed human complement C3a activation in plasma, as indicated by decreased levels of anaphylatoxin production. The results of canine ex vivo blood contacting experiments were conducted in both an acute and chronic model and demonstrated decreased platelet deposition and activation for the sulfonated polyurethanes.

Series shunt evaluation of polyurethane vascular graft materials in chronically AV-shunted canines.

Well characterized, laboratory-synthesized polymeric materials which have been extensively tested for biocompatibility via initial platelet and protein deposition in an acute ex vivo canine model were placed as interpositional series shunts in canines with chronically implanted iliac arteriovenous shunts ex vivo. Platelet deposition was measured on a base polyurethane block copolymer, a sulfonated ionic derivative, an alkyl grafted (C18) derivative, Biomer, polyethylene, and polydimethylsiloxane for 24 h using radiolabeled platelets. Platelet survival and in vitro aggregation were determined to investigate the effects of the shunting procedure on experimental animals. The viability of adopting a chronic arteriovenous (iliac) shunted canine model for use with series shunts to evaluate polyurethanes having applications as materials in vascular graft construction was investigated and the results compared with acute model data.